Otsuka Pharmaceutical

MA strategy deal block push come together form

Otsuka pays $800M for Jnana and its clinical-stage PKU drug

Otsuka has picked up Boston-based Jnana for $800 million so the Japanese biotech can get its hands on a clinical-stage oral phenylketonuria drug.

James Waldron Aug 1, 2024 5:55am

handshake deal shake hand arrows ok yes

Otsuka pays Ionis $65M for European rights to rare disease drug

Dec 19, 2023 10:18am

iris eye eyeball eye art

Otsuka eye disease strategy takes Shape with $1.5B biobucks deal

Sep 8, 2023 8:45am

art psychedelic hallucinogen

Otsuka takes on new Mindset for $59M, delving into psychedelics

Sep 1, 2023 10:55am

blueprint construction hard hat hammer build

UK's Astex adds onto Merck cancer collab for $35M upfront

Aug 8, 2023 4:00am

Photo of a paraglider in the alps

Former BMS R&D chief Vessey jumping to Flagship—Chutes & Ladders

Jul 14, 2023 9:30am